Rocket Doctor Secures Funding to Drive U.S. Market Expansion and Product Innovation
Rocket Doctor (TREIF) secured advisory services and funding to accelerate product development and U.S. expansion. The company received up to $75,000 from NRC IRAP to build a PHIPA- and HIPAA-compliant secure messaging feature supporting 5,000 concurrent users and an internal messaging system for 500 clinicians. The feature targets alignment with Ontario Health Virtual Visit standards, aims to advance OTN certification to Q1 2026, and positions the platform for procurement by over 300 Ontario health service providers. Rocket Doctor also received up to $25,000 from CanExport SMEs to fund U.S. market activities including videos, Spanish translation, targeted ads in New York and California, and conference participation to engage Medicaid plans, hospitals, and FQHCs. The initiatives are expected to create Canadian technical roles and expand revenue opportunities in Ontario and the U.S.
Rocket Doctor (TREIF) ha ottenuto servizi di consulenza e finanziamenti per accelerare lo sviluppo del prodotto e l'espansione negli Stati Uniti. L'azienda ha ricevuto fino a $75,000 dal NRC IRAP per costruire una funzionalità di messaggistica sicura conforme a PHIPA e HIPAA che supporti 5,000 utenti simultanei e un sistema di messaggistica interno per 500 clinici. La funzione punta a allinearsi agli standard Ontario Health Virtual Visit, mira a far avanzare la certificazione OTN a Q1 2026, e posiziona la piattaforma per procurement da parte di oltre 300 fornitori di servizi sanitari dell'Ontario. Rocket Doctor ha anche ricevuto fino a $25,000 dal CanExport SMEs per finanziare attività di mercato negli Stati Uniti tra cui video, traduzione in spagnolo, annunci mirati a New York e California, e partecipazione a conferenze per coinvolgere piani Medicaid, ospedali e FQHC. Le iniziative dovrebbero creare ruoli tecnici canadesi e aumentare le opportunità di ricavi in Ontario e negli Stati Uniti.
Rocket Doctor (TREIF) aseguró servicios de asesoría y financiamiento para acelerar el desarrollo del producto y la expansión en Estados Unidos. La empresa recibió hasta $75,000 de NRC IRAP para construir una función de mensajería segura compatible con PHIPA y HIPAA que soporte 5,000 usuarios concurrentes y un sistema de mensajería interno para 500 clínicos. La función tiene como objetivo alinearse con las normas de Ontario Health Virtual Visit, busca avanzar la certificación OTN a Q1 2026, y posiciona la plataforma para la contratación por más de 300 proveedores de servicios de salud de Ontario. Rocket Doctor también recibió hasta $25,000 de CanExport SMEs para financiar actividades en el mercado estadounidense, incluyendo videos, traducción al español, anuncios dirigidos en Nueva York y California, y participación en conferencias para involucrar planes de Medicaid, hospitales y FQHCs. Se espera que las iniciativas creen roles técnicos canadienses y amplíen las oportunidades de ingresos en Ontario y Estados Unidos.
Rocket Doctor (TREIF)는 제품 개발 가속과 미국 확장을 위해 자문 서비스와 자금을 확보했습니다. 이 회사는 PHIPA 및 HIPAA 준수 보안 메시징 기능을 구축하기 위해 NRC IRAP로 최대 $75,000를 받았으며 5,000명의 동시 사용자를 지원하고 500명의 임상의를 위한 내부 메시징 시스템을 제공합니다. 이 기능은 온타리오 헬스 가상 방문 표준과의 정렬을 목표로 하고 OTN 인증을 2026년 1분기까지 진전시키며 플랫폼을 300개 이상의 온타리오 보건 서비스 제공업체의 조달 대상으로 위치시킵니다. 또한 Rocket Doctor는 미국 시장 활동 자금을 위해 CanExport SMEs로부터 최대 $25,000를 받아 비디오, 스페인어 번역, 뉴욕 및 캘리포니아 대상 맞춤 광고, 컨퍼런스 참여 등을 통해 Medicaid 계획, 병원 및 FQHC를 참여시키려 합니다. 이 이니셔티브는 캐나다의 기술 직무를 창출하고 온타리오와 미국에서 매출 기회를 확대할 것으로 예상됩니다.
Rocket Doctor (TREIF) a obtenu des services de conseil et des financements pour accélérer le développement du produit et l'expansion aux États-Unis. L'entreprise a reçu jusqu'à $75,000 de NRC IRAP pour développer une fonction de messagerie sécurisée conforme à PHIPA et HIPAA, supportant 5 000 utilisateurs simultanés et un système de messagerie interne pour 500 cliniciens. La fonctionnalité vise à s'aligner sur les normes Ontario Health Virtual Visit, à faire progresser la certification OTN vers Q1 2026, et à positionner la plateforme pour l'approvisionnement par plus de 300 prestataires de services de santé de l'Ontario. Rocket Doctor a également reçu jusqu'à $25,000 de CanExport SMEs pour financer des activités sur le marché américain, notamment des vidéos, la traduction espagnole, des publicités ciblées à New York et en Californie, et une participation à des conférences pour engager des plans Medicaid, des hôpitaux et des FQHC. Les initiatives devraient créer des postes techniques canadiens et élargir les opportunités de revenus en Ontario et aux États-Unis.
Rocket Doctor (TREIF) sicherte Beratungsleistungen und Finanzierung, um die Produktentwicklung zu beschleunigen und die Expansion in die USA voranzutreiben. Das Unternehmen erhielt bis zu $75,000 vom NRC IRAP, um eine PHIPA- und HIPAA-konforme sichere Messaging-Funktion zu entwickeln, die 5.000 gleichzeitige Benutzer unterstützt und ein internes Messaging-System für 500 Kliniker bereitstellt. Die Funktion zielt darauf ab, sich an den Ontario Health Virtual Visit-Standards auszurichten, strebt die Weiterentwicklung der OTN-Zertifizierung auf Q1 2026 an und positioniert die Plattform für den Einkauf durch über 300 Ontario Gesundheitsdienstleister. Rocket Doctor erhielt außerdem bis zu $25,000 von CanExport SMEs, um Aktivitäten auf dem US-Markt zu finanzieren, darunter Videos, spanische Übersetzung, zielgerichtete Anzeigen in New York und Kalifornien sowie Teilnahme an Konferenzen, um Medicaid-Pläne, Krankenhäuser und FQHCs zu erreichen. Die Initiativen sollen kanadische technische Stellen schaffen und die Umsatzmöglichkeiten in Ontario und den USA erweitern.
Rocket Doctor (TREIF) حصلت على خدمات استشارية وتمويل لتسريع تطوير المنتج وتوسيعها في الولايات المتحدة. تلقت الشركة حتى $75,000 من NRC IRAP لبناء ميزة مراسلة آمنة تتوافق مع PHIPA وHIPAA تدعم 5,000 مستخدم متزامن ونظام مراسلة داخلي لـ 500 طبيباً ممارساً. تستهدف الميزة التوافق مع معايير Ontario Health Virtual Visit، وتهدف إلى التقدم بشهادة OTN إلى الربع الأول من 2026، وتضع المنصة في موقع المشتريات لأكثر من 300 مقدم خدمات صحية في أونتاريو. كما تلقت Rocket Doctor حتى $25,000 من CanExport SMEs لتمويل أنشطة السوق الأمريكية، بما في ذلك مقاطع فيديو، ترجمة إلى الإسبانية، إعلانات مستهدفة في نيويورك وكاليفورنيا، والمشاركة في مؤتمرات لاستقطاب خطط Medicaid والمستشفيات وFQHCs. من المتوقع أن تخلق المبادرات وظائف تقنية كندية وتوسع فرص الإيرادات في أونتاريو والولايات المتحدة.
Rocket Doctor (TREIF) 已获得顾问服务和资金，以加速产品开发和在美国的扩张。公司从 NRC IRAP 获得最高 $75,000 用于构建符合 PHIPA 和 HIPAA 的安全消息传递功能，支持 5,000 名并发用户，并为 500 名临床医生 提供内部消息传递系统。该功能旨在与安大略省健康虚拟就诊标准保持一致，力争将 OTN 认证提升至 2026 年第 1 季，并将该平台定位为由超过 300 名安大略省卫生服务提供者 采购的对象。Rocket Doctor 还从 CanExport SMEs 获得最高 $25,000 的资金，用于资助美国市场活动，包括视频、西班牙语翻译、在纽约和加利福尼亚的定向广告，以及参与会议以接触 Medicaid 计划、医院和 FQHCs。预计这些举措将创造加拿大的技术岗位并扩大在安大略省和美国的收入机会。
- NRC IRAP support of up to $75,000 for secure-messaging development
- CanExport contribution of up to $25,000 for U.S. market expansion
- Secure messaging built for 5,000 concurrent users
- Internal messaging for 500 clinicians
- OTN certification targeted for Q1 2026
- Positioning for procurement by over 300 Ontario health providers
- None.
Toronto, ON, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) today announced that its wholly-owned digital health platform and marketplace, Rocket Doctor Inc., is receiving advisory services and funding of up to
The NRC IRAP support will be dedicated to the development of a secure, PHIPA- and HIPAA-compliant messaging feature for Rocket Doctor’s care platform. This new capability will enable encrypted, real-time patient–clinician messaging for up to 5,000 concurrent users and a secure internal messaging system for over 500 clinicians. Designed to integrate seamlessly into Rocket Doctor’s workflows, the feature will align with Ontario Health’s Virtual Visit Solution standards, accelerate the company’s OTN certification timeline to Q1 2026, and position the platform for procurement by over 300 Ontario health service providers.
“This support enables us to accelerate development of secure, scalable communications technology that is essential for the future of healthcare,” said Dr. William Cherniak, Founder and CEO of Rocket Doctor Inc. “By ensuring our platform is fully compliant with PHIPA, HIPAA, and Ontario Health standards, we are not only serving Ontario patients, but also ensuring readiness across Canada, as well as for U.S. health systems, Medicaid / Medicare plans, and Commercial partners.”
Complementing this support is the CanExport contribution of
These combined initiatives are expected to create new technical roles in Canada, enabling engineering resources to accelerate roadmap priorities, while increasing revenue potential through expanded eligibility for public procurement in Ontario and new deal flow in the United States. The secure-messaging platform enhancements will also increase adoption by equipping clinicians and patients with user-friendly communication tools that meet rigorous regulatory standards. Rocket Doctor’s growing software platform and expansion in the United States underscores its commitment to removing barriers to care, improving health equity, and leveraging Canadian innovation to solve cross-continental healthcare challenges.
About Rocket Doctor AI Inc.
Rocket Doctor AI Inc. delivers physician-built, AI-powered solutions designed to make high-quality healthcare accessible throughout the entire patient journey. A cornerstone of the company’s proprietary technology is the Global Library of Medicine (GLM), a clinically validated decision support system developed with input from hundreds of physicians worldwide.
Alongside the GLM is Rocket Doctor Inc, and its AI-powered digital health platform and marketplace. Having helped empower over 300 MDs to provide care to more than 700,000 patient visits, our proprietary technology software and systems enable doctors to independently launch and manage their own virtual or hybrid in-person practices - improving efficiency, restoring autonomy to MDs, and expanding patient access to care.
By reducing administrative burdens and ensuring greater consistency in care, our technology creates more time for meaningful physician-patient interactions. We are committed to reaching underserved, rural, and remote communities in Canada who often lack access to family doctors and supporting patients on Medicaid and Medicare in the United States. With advanced AI, large language models, and connected medical devices, Rocket Doctor AI is redefining modern healthcare - making it more scalable, equitable, and patient-centered.
To learn more about Rocket Doctor AI Inc’s products and services, contact:
www.rocketdoctor.ai or email: info@rocketdoctor.ai
FOR ADDITIONAL INFORMATION, CONTACT:
Dr. Essam Hamza, CEO, Rocket Doctor AI
essam.hamza@rocketdoctor.ai
Dr. Bill Cherniak, CEO, Rocket Doctor Inc.
bill@rocketdoctor.io
For media inquiries, contact: media@rocketdoctor.ai
Call: +1 (778) 819 8321
Cautionary Statements
This news release contains forward-looking statements relating to the future operations of Rocket Doctor AI Inc. and other statements that are not historical facts. Forward-looking statements are often identified by terms such as "will", "may", "should", "anticipate", "expects" and similar expressions. All statements other than statements of historical fact, included in this release, including, without limitation, statements regarding the Offering, the use of proceeds of the Offering, the filing of a Prospectus Supplement and future plans and objectives of Rocket Doctor AI Inc., are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from Rocket Doctor AI Inc.'s expectations include other risks detailed from time to time in the filings made by Rocket Doctor AI Inc. with securities regulators.
The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of Rocket Doctor AI Inc. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and Rocket Doctor AI Inc. will only update or revise publicly the included forward-looking statements as expressly required by Canadian securities law.
FAQ
What funding did Rocket Doctor announce on October 9, 2025 (TREIF)?
What will Rocket Doctor use the NRC IRAP funds for (TREIF)?
What capacity will the new secure messaging support for Rocket Doctor (TREIF)?
When does Rocket Doctor expect OTN certification for the secure messaging (TREIF)?
How will the CanExport funds be used to support U.S. growth for Rocket Doctor (TREIF)?
What commercial impact does Rocket Doctor expect from these initiatives (TREIF)?
